康龙化成(300759)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300759 康龙化成

交易中 05-06 13:39:39

{"stockData":{"symbol":"300759","market":"SZ","secType":"STK","nameCN":"康龙化成","latestPrice":20.33,"timestamp":1714973979000,"preClose":19.75,"halted":0,"volume":24189182,"delay":0,"floatShares":1429000000,"shares":1787000000,"eps":0.83,"marketStatus":"交易中","marketStatusCode":2,"change":0.58,"latestTime":"05-06 13:39:39","open":20.08,"high":20.75,"low":19.96,"amount":494000000,"amplitude":0.04,"askPrice":20.33,"askSize":589,"bidPrice":20.32,"bidSize":1,"shortable":0,"etf":0,"ttmEps":0.83,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1714978800000},"adr":0,"adjPreClose":19.75,"symbolType":"stock","openAndCloseTimeList":[[1714959000000,1714966200000],[1714971600000,1714978800000]],"highLimit":21.73,"lowLimit":17.78,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1787394297,"pbRate":2.81,"roa":"--","roe":"1.83%","epsLYR":0.9033,"committee":0.290522,"marketValue":36338000000,"floatMarketCap":29043000000,"peRate":24.493976,"changeRate":0.0294,"turnoverRate":0.0169,"status":0},"requestUrl":"/m/hq/s/300759/wiki","defaultTab":"wiki","newsList":[{"id":"2433467951","title":"CRO概念股早盘涨幅居前 药明生物及康龙化成均涨逾7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433467951","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2433467951?lang=zh_cn&edition=full","pubTime":"2024-05-06 10:26","pubTimestamp":1714962360,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　CRO概念股早盘涨幅居前，药明生物（02269）上涨7.16%，报14.96港元；康龙化成（03759）上涨6.73%，报10.62港元；泰格医药（03347）上涨6.24%，报36.60港元；明康德（02359）上涨3.55%，报37.90港元。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-05-06/doc-inaufyzc3364003.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-05-06/doc-inaufyzc3364003.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433618804","title":"康龙化成(03759)上涨5.13%，报10.46元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2433618804","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2433618804?lang=zh_cn&edition=full","pubTime":"2024-05-06 09:44","pubTimestamp":1714959842,"startTime":"0","endTime":"0","summary":"5月6日，康龙化成(03759)盘中上涨5.13%，截至09:44，报10.46元/股，成交1119.5万元。康龙化成是一家国际领先的生命科学研发服务企业，主要为小分子、大分子和细胞与基因治疗药物的研发提供全流程的研发生产服务。公司在中国、美国、英国开展运营，拥有14,000多名员工，服务的主要市场包括北美、欧洲、日本和中国。截至2024年一季报，康龙化成营业总收入26.71亿元、净利润2.31亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/06094440522788.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2432992594","title":"康龙化成(03759)下跌5.15%，报9.94元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2432992594","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2432992594?lang=zh_cn&edition=full","pubTime":"2024-05-03 10:37","pubTimestamp":1714703839,"startTime":"0","endTime":"0","summary":"5月3日，康龙化成(03759)盘中下跌5.15%，截至10:37，报9.94元/股，成交417.35万元。康龙化成是一家国际领先的生命科学研发服务企业，主要为小分子、大分子和细胞与基因治疗药物的研发提供全流程的研发生产服务。公司在中国、美国、英国开展运营，拥有14,000多名员工，服务的主要市场包括北美、欧洲、日本和中国。截至2024年一季报，康龙化成营业总收入26.71亿元、净利润2.31亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/03103740513578.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431630038","title":"康龙化成(03759)拟回购2亿-3亿元A股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2431630038","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431630038?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:32","pubTimestamp":1714397550,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康龙化成 公布，鉴于截至 2024 年 4 月 19 日公司A 股股票连续 20 个交易日内股票收盘价格跌幅累计超过 20%，为维护公司价值及股东权益所必需，切实推动“质量回报双提升”行动方案的实施，公司拟使用自有资金以集中竞价交易方式回购公司部分人民币普通股 A 股股份。本次回购资金总额为不低于人民币 2 亿元且不超过人民币 3 亿元，回购价格上限不超过人民币 31 元/股(含)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1115156.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431836180","title":"开源证券：给予康龙化成买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2431836180","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431836180?lang=zh_cn&edition=full","pubTime":"2024-04-29 18:21","pubTimestamp":1714386075,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,汪晋近期对康龙化成进行研究并发布了研究报告《公司信息更新报告：2024Q1业绩阶段性承压，新业务推进打开成长空间》，本报告对康龙化成给出买入评级，当前股价为19.95元。截至2023年底，已为26个CGT项目提供分析测试服务，为13个基因治疗项目提供CDMO服务。最新盈利预测明细如下：该股最近90天内共有22家机构给出评级，买入评级17家，增持评级4家，中性评级1家；过去90天内机构目标均价为25.27。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900024323.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431502926","title":"浦银国际证券：给予康龙化成中性评级，目标价位22.4元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431502926","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431502926?lang=zh_cn&edition=full","pubTime":"2024-04-29 11:05","pubTimestamp":1714359930,"startTime":"0","endTime":"0","summary":"浦银国际证券有限公司胡泽宇,阳景近期对康龙化成进行研究并发布了研究报告《1Q24业绩不及预期，但新签订单增速超预期》，本报告对康龙化成给出中性评级，认为其目标价位为22.40元，当前股价为19.98元，预期上涨幅度为12.11%。　　康龙化成　　有”评级，略微下调目标价至22.4元。维持A股“持有”评级，给予A股目标价较港股目标价60%的溢价，对应A股目标价人民币22.4元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900007555.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431028481","title":"康龙化成(03759)上涨5.06%，报9.96元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431028481","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431028481?lang=zh_cn&edition=full","pubTime":"2024-04-29 10:22","pubTimestamp":1714357365,"startTime":"0","endTime":"0","summary":"4月29日，康龙化成(03759)盘中上涨5.06%，截至10:22，报9.96元/股，成交1752.81万元。康龙化成是一家国际领先的生命科学研发服务企业，主要为小分子、大分子和细胞与基因治疗药物的研发提供全流程的研发生产服务。公司在中国、美国、英国开展运营，拥有14,000多名员工，服务的主要市场包括北美、欧洲、日本和中国。截至2024年一季报，康龙化成营业总收入26.71亿元、净利润2.31亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/29102240459718.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430032501","title":"信达证券发布康龙化成研报 新签订单同比增长20%+ 全年有望逐渐回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=2430032501","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2430032501?lang=zh_cn&edition=full","pubTime":"2024-04-28 17:57","pubTimestamp":1714298220,"startTime":"0","endTime":"0","summary":"信达证券04月28日发布康龙化成（300759.SZ，最新价：19.16元）研报。要点包括：1）事件：康龙化成发布2024年一季报；2）业务整合影响利润率表现，费用率小幅上升；3）行业环境遇冷致业绩承压，多指标释放复苏信号；4）客户数量持续增长，新签订单同比增长20%+，支撑长期稳定发展。风险提示：行业竞争加剧、研发投入及外包需求下降、政策风险、新业务拓展不及预期等风险。AI点评：康龙化成近一个月获得9份券商研报关注，买入4家，平均目标价为25.52元，与最新价19.16元相比，高6.36元，目标均价涨幅33.19%。（文章来源：每日经济新闻）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042817593687ba6bef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042817593687ba6bef&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430808390","title":"康龙化成：4月26日接受机构调研，高盛证券、海通证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2430808390","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430808390?lang=zh_cn&edition=full","pubTime":"2024-04-28 16:05","pubTimestamp":1714291520,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年4月28日康龙化成发布公告称公司于2024年4月26日接受机构调研，高盛证券、海通证券、中信建投、广发证券、中信证券、国金证券、兴业证券、中欧基金、汇丰晋信、汇添富基金、华夏基金、华泰证券、嘉实基金、华泰资产、信达澳银、天弘基金、鹏华基金、国盛证券、浙商证券、中金证券、长江证券、招商证券、野村证券、招商国际参与。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800003505.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430970915","title":"平安证券：给予康龙化成增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430970915","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430970915?lang=zh_cn&edition=full","pubTime":"2024-04-28 11:04","pubTimestamp":1714273451,"startTime":"0","endTime":"0","summary":"平安证券股份有限公司叶寅,倪亦道,张若昳近期对康龙化成进行研究并发布了研究报告《静待拐点，订单端初显改善迹象》，本报告对康龙化成给出增持评级，当前股价为19.16元。考虑到公司成熟业务稳定增长提供业绩保障，新兴业务盈利质量或将改善，维持“推荐”评级。最新盈利预测明细如下：该股最近90天内共有20家机构给出评级，买入评级17家，增持评级2家，中性评级1家；过去90天内机构目标均价为26.34。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800001479.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430244320","title":"康龙化成涨5.04%，民生证券四周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430244320","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430244320?lang=zh_cn&edition=full","pubTime":"2024-04-26 16:26","pubTimestamp":1714119971,"startTime":"0","endTime":"0","summary":"今日康龙化成涨5.04%，收盘报19.16元。2024年3月28日，民生证券研究员王班,乔波耀发布了对康龙化成的研报《2023年年报点评：一体化平台稳健成长，积极推进新产能投放和新能力建设》，该研报对康龙化成给出“买入”评级。此外，开源证券研究员余汝意,汪晋，国投证券研究员马帅,冯俊曦近期也对该股发布了研报，同样给出“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为民生证券的孙建。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600035369.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430921882","title":"康龙化成(03759)股价上升5.114%，现价港币$9.25","url":"https://stock-news.laohu8.com/highlight/detail?id=2430921882","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2430921882?lang=zh_cn&edition=full","pubTime":"2024-04-26 11:04","pubTimestamp":1714100640,"startTime":"0","endTime":"0","summary":"[上升股]康龙化成(03759) 股价在上午11:04比前收市价上升5.114%，现股价为港币$9.25。至目前为止，今日最高价为$9.25，而最低价为$8.71。总成交量为315.67万股，总成交金额为港币$2.861千万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404262438/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2430230942","title":"图解康龙化成一季报：第一季度单季净利润同比减33.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430230942","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430230942?lang=zh_cn&edition=full","pubTime":"2024-04-26 02:08","pubTimestamp":1714068520,"startTime":"0","endTime":"0","summary":"证券之星消息，康龙化成2024年一季报显示，公司主营收入26.71亿元，同比下降1.95%；归母净利润2.31亿元，同比下降33.8%；扣非净利润1.87亿元，同比下降46.01%；负债率47.09%，投资收益4656.92万元，财务费用6343.8万元，毛利率32.66%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600002924.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430423293","title":"《业绩》康龙化成(03759.HK)首季净利润2.31亿人民币  倒退33.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430423293","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2430423293?lang=zh_cn&edition=full","pubTime":"2024-04-26 01:28","pubTimestamp":1714066080,"startTime":"0","endTime":"0","summary":"康龙化成(03759.HK) 公布3月止第一季度报告，按中国会计准则，实现营业收入26.71亿人民币(下同)，按年下降2%。归属股东净利润2.31亿元，倒退33.8%，原因是营业收入阶段性下降，营业成本、费用增加所致；每股收益13分。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-25 16:25。)过往派息公布日期派息事项派息内容2024/03/27末期业绩普通股息：人民币 0.22023/10/29第三季业绩无派息2023/08/27中期业绩无派息2023/04/27第一季业绩无派息 AASTOCKS新闻","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20181030154132161_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20181030154132161_s.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1345193/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2430232935","title":"康龙化成(03759.HK)建议回购A股  资金上限3亿人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2430232935","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2430232935?lang=zh_cn&edition=full","pubTime":"2024-04-26 01:28","pubTimestamp":1714066080,"startTime":"0","endTime":"0","summary":"康龙化成(03759.HK) 公布，拟以竞价交易方式回购公司A股，每股价格不超过31元人民币，资金总额为不低于2亿人民币且不超过3亿人币。预计回购A股股数介乎645.16-967.74万股。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-25 16:25。)AASTOCKS新闻","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20210817120930413_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20210817120930413_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1345194/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2430239073","title":"康龙化成(300759.SZ)发布一季度业绩，净利润2.31亿元，下降33.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430239073","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430239073?lang=zh_cn&edition=full","pubTime":"2024-04-26 00:41","pubTimestamp":1714063311,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康龙化成(300759.SZ)发布2024年第一季度报告，该公司营业收入为26.71亿元，同比减少1.95%。归属于上市公司股东的净利润为2.31亿元，同比减少33.80%。归属于上市公司股东的扣除非经常性损益的净利润为1.87亿元，同比减少46.01%。基本每股收益为0.13元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111099.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430288771","title":"康龙化成(03759)：严洛钧获委任为公司秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2430288771","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430288771?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:13","pubTimestamp":1714050789,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康龙化成(03759)发布公告，麦宝文已辞任公司的公司秘书，及不再担任公司授权代表及法律程序文件代理人，自2024年4月25日生效。此外，严洛钧已获委任为公司秘书、授权代表及法律程序文件代理人，自2024年4月25日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1110580.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430860288","title":"康龙化成(03759)公布一季度业绩 归母净利约2.31亿元 同比减少33.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430860288","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430860288?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:00","pubTimestamp":1714050044,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康龙化成(03759)公布2024年第一季度业绩，营业收入约26.71亿元，同比减少1.95%;归属于上市公司股东的净利润约2.31亿元，同比减少33.8%;扣非净利约1.87亿元，同比减少46.01%;基本每股收益0.13元。受到全球医药健康行业投融资阶段性遇冷、客户需求增速暂时放缓的市场环境影响，报告期内，公司营业收入阶段性下降。2024年第一季度，公司全球客户询单和访问较2023年同期有所回暖，报告期内，公司新签订单金额同比增长超过20%。公告称，净利减少主要系报告期营业收入阶段性下降，营业成本、期间费用同比增加综合所致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1110549.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430407016","title":"康龙化成最新公告：一季度净利润同比下降33.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430407016","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430407016?lang=zh_cn&edition=full","pubTime":"2024-04-25 20:40","pubTimestamp":1714048848,"startTime":"0","endTime":"0","summary":"康龙化成发布2024年一季度报告，第一季度归母净利润2.31亿元，同比下降33.8%。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500043511.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2425997072","title":"【港股通】康龙化成(03759)斥资2.8亿元人民币参投甬欣康君基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2425997072","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2425997072?lang=zh_cn&edition=full","pubTime":"2024-04-08 21:21","pubTimestamp":1712582489,"startTime":"0","endTime":"0","summary":"金吾财讯 | 康龙化成 公告，于2024年4月8日，康君投资与八名有限合伙人就投资甬欣康君基金订立有限合伙协议。康龙化成为甬欣康君基金的投资方之一，投资金额为人民币2.8亿元，占比31.11%。甬欣康君基金的目标募集规模上限暂定为人民币20亿元。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/MGVkMTYyODU4OTM2NDU2Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MGVkMTYyODU4OTM2NDU2Mg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1934631","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2019-01-28","address":"北京市大兴区北京经济技术开发区泰河路6号1幢八层","stockEarnings":[{"period":"1week","weight":0.0699},{"period":"1month","weight":-0.0304},{"period":"3month","weight":-0.064},{"period":"6month","weight":-0.3919},{"period":"1year","weight":-0.3902},{"period":"ytd","weight":-0.3185}],"companyName":"康龙化成(北京)新药技术股份有限公司","boardCode":"AI0073","perCapita":"--","boardName":"研究和试验发展","registeredCapital":"178739万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":"　　康龙化成(北京)新药技术股份有限公司主营业务是从药物发现到药物开发的全流程一体化药物研究、开发及生产服务。公司的主要服务为实验室服务、CMC(小分子CDMO)服务、临床研究服务、大分子和细胞与基因治疗服务四大服务板块。","serverTime":1714973981630,"listedPrice":7.66,"stockholders":"0人","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康龙化成(300759)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康龙化成(300759)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康龙化成,300759,康龙化成股票,康龙化成股票老虎,康龙化成股票老虎国际,康龙化成行情,康龙化成股票行情,康龙化成股价,康龙化成股市,康龙化成股票价格,康龙化成股票交易,康龙化成股票购买,康龙化成股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康龙化成(300759)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康龙化成(300759)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}